HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qian Shen Selected Research

Holliday Junction Resolvases

3/2019Gen1 Modulates Metanephric Morphology Through Retinoic Acid Signaling.
1/2018Disruption of Gen1 Causes Congenital Anomalies of the Kidney and Urinary Tract in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qian Shen Research Topics

Disease

34Neoplasms (Cancer)
03/2022 - 07/2007
17Malaria
01/2022 - 04/2014
12Proteinuria
07/2022 - 08/2010
10Nephrotic Syndrome (Syndrome, Nephrotic)
01/2022 - 06/2005
9Neoplasm Metastasis (Metastasis)
01/2022 - 10/2010
8Stomach Neoplasms (Stomach Cancer)
01/2022 - 03/2016
7Cognitive Dysfunction
01/2022 - 01/2009
7Cakut
01/2022 - 01/2019
6Breast Neoplasms (Breast Cancer)
12/2021 - 02/2003
5Kidney Diseases (Kidney Disease)
03/2022 - 03/2011
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 04/2014
5Infections
01/2021 - 12/2013
5Inflammation (Inflammations)
01/2020 - 06/2005
5Atrophy
05/2013 - 10/2008
4Systemic Lupus Erythematosus (Libman-Sacks Disease)
07/2022 - 02/2005
4Hepatocellular Carcinoma (Hepatoma)
01/2022 - 02/2015
4Chronic Renal Insufficiency
01/2022 - 02/2012
4COVID-19
01/2022 - 01/2020
4Vesico-Ureteral Reflux (Vesicoureteral Reflux)
01/2022 - 01/2014
4Disease Progression
01/2021 - 08/2012
4Chronic Hepatitis B
04/2016 - 01/2010
4Alzheimer Disease (Alzheimer's Disease)
05/2013 - 01/2009
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 01/2021
3Pain (Aches)
12/2021 - 10/2020
3Chronic Kidney Failure (Chronic Renal Failure)
07/2021 - 01/2020
3Fever (Fevers)
01/2021 - 06/2011
3Rheumatoid Arthritis
01/2021 - 10/2005
3Lung Neoplasms (Lung Cancer)
01/2018 - 09/2010
3Pneumonia (Pneumonitis)
01/2018 - 03/2012
3Hypertension (High Blood Pressure)
12/2017 - 08/2010
3Autoimmune Diseases (Autoimmune Disease)
08/2012 - 01/2009
2Peritonitis
10/2022 - 01/2021
2Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 08/2021
2Fetal Growth Retardation (Intrauterine Growth Retardation)
03/2022 - 03/2011
2Urinary Tract Infections (Urinary Tract Infection)
01/2022 - 01/2014
2Cicatrix (Scar)
01/2022 - 07/2008
2Renal Insufficiency (Renal Failure)
01/2022 - 01/2022
2Neutropenia
01/2022 - 01/2018
2Adenocarcinoma
01/2022 - 04/2014
2Coenzyme Q10 Deficiency
01/2022 - 01/2022
2Asthma (Bronchial Asthma)
12/2021 - 06/2005
2Parkinson Disease (Parkinson's Disease)
11/2021 - 06/2008
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2021 - 01/2021
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2021 - 01/2018
2Anemia
01/2021 - 06/2011
2Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 05/2015
2Hematuria
10/2020 - 08/2019

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
07/2022 - 06/2005
19artemisinin (artemisinine)IBA
01/2022 - 01/2011
10Pharmaceutical PreparationsIBA
03/2021 - 11/2011
10Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2009
9SesquiterpenesIBA
01/2022 - 01/2015
7CytokinesIBA
01/2022 - 06/2005
5LactonesIBA
01/2022 - 01/2016
5SteroidsIBA
01/2022 - 02/2014
5CrizotinibIBA
11/2021 - 04/2017
5DNA (Deoxyribonucleic Acid)IBA
10/2021 - 10/2008
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 04/2014
5Pemetrexed (MTA)FDA Link
01/2018 - 07/2011
4Rituximab (Mabthera)FDA Link
01/2022 - 02/2014
4CreatinineIBA
01/2022 - 06/2011
4Small Interfering RNA (siRNA)IBA
01/2022 - 08/2012
4Messenger RNA (mRNA)IBA
01/2021 - 02/2003
3Long Noncoding RNAIBA
02/2022 - 01/2020
3Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 07/2014
3EnzymesIBA
01/2022 - 01/2011
3Succimer (Dimercaptosuccinic Acid)FDA Link
01/2022 - 07/2008
3Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2022 - 01/2020
3AutoantibodiesIBA
09/2021 - 03/2012
3Blood Glucose (Blood Sugar)IBA
01/2021 - 07/2007
3ErbB Receptors (EGF Receptor)IBA
01/2021 - 01/2021
3Tyrosine Kinase InhibitorsIBA
01/2021 - 01/2021
3Anaplastic Lymphoma KinaseIBA
07/2020 - 01/2018
3HMGB1 Protein (HMG1)IBA
01/2016 - 11/2009
2Chondroitin Sulfates (Chondroitin Sulfate)IBA
03/2022 - 08/2021
2Antiviral Agents (Antivirals)IBA
01/2022 - 12/2013
2ubiquinone 6IBA
01/2022 - 01/2022
2talazoparibIBA
01/2022 - 01/2017
2coenzyme Q10 (CoQ10)IBA
01/2022 - 01/2020
2AZD5153IBA
01/2022 - 01/2019
2adavosertibIBA
10/2021 - 02/2018
2Immune Checkpoint InhibitorsIBA
10/2021 - 01/2021
2LipidsIBA
03/2021 - 02/2018
2MicroRNAs (MicroRNA)IBA
01/2021 - 02/2015
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2021 - 03/2016
2Therapeutic UsesIBA
01/2021 - 06/2005
2BerberineIBA
01/2021 - 12/2017
2LigandsIBA
01/2021 - 10/2005
23' Untranslated Regions (3' UTR)IBA
01/2021 - 04/2019
2Immunosuppressive Agents (Immunosuppressants)IBA
01/2021 - 02/2014
2Circular RNAIBA
01/2021 - 01/2021

Therapy/Procedure

29Therapeutics
03/2022 - 09/2010
9Drug Therapy (Chemotherapy)
01/2021 - 08/2012
5Peritoneal Dialysis
10/2022 - 01/2020
4Kidney Transplantation
07/2021 - 07/2011
3Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 01/2015
3Length of Stay
12/2021 - 01/2021
3Immunotherapy
10/2021 - 01/2021
2Aftercare (After-Treatment)
07/2022 - 01/2021
2Radiotherapy
10/2020 - 01/2019